A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
α1-Adrenergic Receptor Antagonists: Novel Therapy for Pituitary Adenomas
2005
Molecular Endocrinology
Pituitary tumors are common and cause considerable morbidity due to local invasion and altered hormone secretion. Doxazosin (dox), a selective ␣ 1 -adrenergic receptor antagonist, used to treat hypertension, also inhibits prostate cancer cell proliferation. We examined the effects of dox on murine and human pituitary tumor cell proliferation in vitro and in vivo. dox treatment inhibited proliferation of murine pituitary tumor cells, induced G 0 -G 1 cell cycle arrest, and reduced phosphorylated
doi:10.1210/me.2004-0471
pmid:16020484
fatcat:jkpnnffbqjhz5l7eusymbj6fjq